EMS-Chemie stock stays anchored by 2025 sales growth
Published on 07/24/2026 at 11:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
EMS-Chemie (CH0016440353) is shaped by 2025 sales growth, a 2025 operating margin of 29.9% and a CHF 1.70 billion market capitalization noted in recent market data. The Swiss specialty chemicals group reported 2025 net sales of CHF 2.07 billion, up 1.0% from 2024, while operating profit reached CHF 618 million, according to the companys latest investor-relations materials.
Sales rise 1.0%
EMS-Chemie reported 2025 net sales of CHF 2.07 billion, compared with CHF 2.05 billion in 2024, a year-on-year increase of 1.0%. Operating profit was CHF 618 million in 2025, which implies an operating margin of 29.9% and shows why the group remains one of the most profitable names in its niche.
That combination matters because the revenue base is still relatively compact, but the margin structure stays high. A 29.9% operating margin on CHF 2.07 billion sales leaves little room for disappointment, especially when demand trends are uneven across industrial end markets.
Margin near 30%
The 2025 margin of 29.9% sits close to the psychological 30% threshold and gives investors a clean reference point for 2026 comparisons. The companys 2025 operating profit of CHF 618 million also provides a concrete base for tracking whether pricing power and product mix remain intact.
For a specialty chemicals group, the key question is not just volume, but how much of every franc of sales turns into operating profit. On that score, EMS-Chemie still reported a level that many larger industrial peers would regard as premium.
EMS-Chemie 2025 numbers at a glance
The latest investor-relations figures highlight sales, margin and profit discipline in one place.
2025 base remains strong
The 2025 numbers give EMS-Chemie a high-quality earnings base even without a fresh catalyst in the text. With CHF 2.07 billion in sales and CHF 618 million in operating profit, the group enters the next reporting cycle with a solid historical comparison already built in.
That is useful for market watchers because a company with a 29.9% operating margin usually trades on execution and resilience rather than pure growth. The next step is whether the 2026 mix can sustain that level against slower industrial demand.
Auto materials still matter
One of EMS-Chemies best-known product areas is engineering plastics for automotive and industrial applications, which remain important for revenue mix and margin quality. The company has long relied on specialty materials rather than commodity exposure, and the 2025 figures suggest that model still supports above-average profitability.
That product focus helps explain why the group can keep margins elevated even when end-market demand is not especially strong. It also makes the sales trend more relevant than it may appear at first glance, because a 1.0% increase on CHF 2.07 billion is still meaningful at this margin level.
CHF 1.70 billion value
Recent market data placed EMS-Chemie at a market capitalization of about CHF 1.70 billion, giving the 2025 profit base a visible valuation frame. Used against CHF 618 million of operating profit, that scale underlines how the market is still paying close attention to earnings durability.
For Swiss investors, the stock remains a straightforward profit-and-quality story: sales at CHF 2.07 billion in 2025, operating profit at CHF 618 million and a 29.9% margin are the key reference points. The share is therefore best read through execution and valuation rather than narrative noise.
EMS-Chemie stock at a glance
- Company: EMS-Chemie Holding AG
- ISIN: CH0016440353
- Ticker: SIX: EMS
- Trading venue: SIX Swiss Exchange
- Market capitalization: CHF 1.70 billion
- Sector / Industry: Materials - Specialty Chemicals
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
